abbott stock price — NYSE ABT overview
Abbott stock price
This article covers the market price, trading data, historical performance and investor-relevant information for Abbott Laboratories common stock (NYSE: ABT). If you want to understand the current abbott stock price, what moves it, and practical ways to monitor or trade ABT, this guide provides a comprehensive, beginner-friendly reference and points to authoritative data sources for real-time updates.
Company overview
Abbott Laboratories is a diversified global healthcare company founded in 1888 and headquartered in Abbott Park, Illinois, USA. The business operates through several principal segments: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals. Abbott develops and sells products ranging from cardiac devices, continuous glucose monitoring systems, diagnostics instruments and assays, to branded nutrition products and generic pharmaceuticals. Because Abbott operates across products that receive regulatory approvals, clinical data, and consumer demand cycles, investors follow the abbott stock price closely for both defensive and growth-oriented capital allocation decisions.
Security identifiers and listing details
- Ticker symbol: ABT
- Exchange: New York Stock Exchange (NYSE)
- Trading currency: U.S. dollars (USD)
- Common identifiers: International Securities Identification Number (ISIN) and CUSIP identifiers are published in Abbott’s investor materials and SEC filings; consult the company’s investor relations or official filings to verify exact codes.
- Trading hours (regular): U.S. equities regular session typically runs 09:30–16:00 ET. Pre-market and after-hours trading windows also exist where a variant of the abbott stock price may be quoted (see below).
Knowing the ticker (ABT) and exchange (NYSE) is sufficient for locating live and delayed price quotes across major market data providers.
Real-time and delayed price feeds
Market platforms and financial portals provide quotes for ABT with either real-time or delayed data depending on their subscriptions and regulatory access. Common data providers and platforms where you can view the abbott stock price include: Yahoo Finance, Google Finance, CNBC, Robinhood, MarketWatch, Morningstar, and Abbott’s official investor relations pages.
Key quote terms to understand:
- Last trade / Last price: the most recent executed trade price — often shown as the primary abbott stock price on screens.
- Bid / Ask: the current best bid (highest buyer price) and best ask (lowest seller price). The bid-ask spread reflects immediate liquidity.
- Change / % Change: difference and percent change versus the prior close.
- After-hours / Pre-market: trades executed outside regular session; these quotes can differ from the regular-session abbott stock price and can be more volatile and thinner in liquidity.
Note: Some retail platforms display real-time data for free; other portals may show a 15–20 minute delayed abbott stock price unless you have a real-time market data subscription.
Key price metrics and valuation data
Commonly reported metrics that help contextualize the abbott stock price include:
- Current price (last trade)
- Absolute change and percent change (vs prior close)
- 52-week high and low
- Market capitalization (share price × shares outstanding)
- Price-to-earnings (P/E) ratio
- Earnings per share (EPS), trailing and forward
- Price/sales, price/book
- Dividend yield and most recent dividend per share
- Analyst consensus price targets and ratings
Where to find them: financial portals (Yahoo Finance, Morningstar, Google Finance, MarketWatch), broker platforms, and Abbott’s investor relations pages all publish these metrics. Because these figures and multiple ratio calculations change as prices and company reports update, consult live data providers for the current abbott stock price and derived metrics.
As of January 24, 2026, several market reports noted the following company-level figures in connection with a quarter of earnings news: Abbott’s market capitalization was reported near $209.9 billion, and the abbott stock price traded around the low-to-mid $100 range following its Q4 CY2025 results and guidance (sources: Benzinga/Barchart reporting and Abbott investor communications). For the latest market capitalization and computed ratios, view a live quote feed or Abbott’s filings.
Historical price performance
Historical price data for ABT is useful for short-term traders and long-term investors. Sources for time series include Yahoo Finance, Google Finance, Morningstar, MarketWatch, and the company’s investor site. Historical information typically includes daily open/high/low/close values, volume, and adjusted close (for dividends and splits).
Important historical price considerations:
- Total return: when assessing long-term performance, include dividends and dividend reinvestment (total return), not just price appreciation.
- Milestones: large corporate actions (spin-offs, acquisitions), major product approvals, or safety events often mark large, discrete price moves.
Intraday and short-term performance
Intraday monitoring highlights minute-to-minute price action and volume. Typical short-term factors affecting the abbott stock price include earnings releases, regulatory announcements (e.g., FDA approvals or safety alerts), macroeconomic moves that shift risk appetite, and sector news affecting healthcare and medtech peers.
Common intraday indicators traders use:
- Volume spikes (indicate strong participation)
- Bid-ask spread changes (liquidity shifts)
- Price/volume divergences
- Short-term moving averages and momentum indicators
Long-term trends and total return
For long-term investors, look at multi-year charts and total-return series that incorporate dividends. Abbott has a multi-decade history of dividend payments and periodic share buybacks; these corporate actions materially affect long-term returns. When evaluating long-term performance, focus on compound annual growth rates of revenue and EPS, product pipeline success, and structural trends in healthcare demand.
Trading characteristics and liquidity
Abbott is a large-cap company with high liquidity relative to smaller stocks. Typical trading characteristics include:
- Average daily volume: commonly measured in the millions of shares (varies day-to-day). Volume often spikes on earnings releases or material corporate news.
- Float and shares outstanding: public filings list fully diluted shares outstanding and the free float. These affect how easily large orders execute.
- Bid-ask spread: for large-cap, highly traded stocks like ABT, spreads are usually narrow during regular hours; they can widen in extended hours.
Liquidity implications for traders: narrower spreads and higher volumes generally result in better execution for market and limit orders; however, during earnings or major news events, volatility and spreads can widen suddenly.
Dividends, splits and corporate actions
Abbott has historically paid dividends and conducted periodic share repurchases. Corporate events that affect the abbott stock price include:
- Dividends: ex-dividend and record dates are published in the investor relations calendar and SEC filings. Dividend payments increase total return but may cause short-term price adjustments on the ex-dividend date.
- Stock splits: if announced, splits change the per-share price and share count while preserving market capitalization.
- Mergers & acquisitions: large acquisitions or divestitures can materially change future cash flows and the abbott stock price.
Example corporate action (recent): in November 2025 Abbott announced the acquisition of Exact Sciences in a roughly $21 billion deal, a material corporate event that market participants considered in valuation and price expectations (reported Nov 2025; see investor communications and press coverage).
Always check Abbott’s investor relations announcements and SEC filings for authoritative ex-dividend dates, split details, and transaction terms.
Financials and earnings that drive price
Quarterly and annual financial reports (revenue, EPS, margins, segment performance, and guidance) are primary drivers of the abbott stock price. Key elements that influence price reaction include:
- Revenue beats or misses and the drivers by segment (Devices, Diagnostics, Nutrition, Established Pharmaceuticals)
- Margin expansion or compression
- Management guidance for the upcoming quarter and fiscal year
- One-time items (acquisitions, restructuring charges)
Recent example: Abbott reported Q4 CY2025 revenue of $11.46 billion (reported as a 4.4% year-on-year increase) with adjusted EPS of $1.50. The top-line missed consensus estimates, and first-quarter guidance and 2026 organic sales expectations contributed to price weakness following the release (reported as of January 24, 2026 by market outlets covering the earnings announcement). These quarter results and guidance revisions materially influenced the abbott stock price in the immediate trading sessions.
Where to read reports and filings: Abbott’s investor relations site posts earnings releases, slide decks, and webcasts. SEC filings (10-Q, 10-K, 8-K) provide complete financial statements and disclosures.
Major news and events affecting ABT price
Categories of news that commonly move the abbott stock price:
- FDA approvals, clearances, or safety alerts for devices and diagnostics
- Clinical trial results or new product launches
- Mergers & acquisitions and large licensing deals
- Significant changes in consumer demand (impacting Nutrition segment)
- Regulatory investigations or recalls
- Macroeconomic and market risk events (rate moves, risk-on/risk-off rotations)
Recent examples reported (as of January 24, 2026):
- Abbott’s Q4 CY2025 sales missed expectations and company guidance for 2026 was described by some sell-side notes as conservative; media reported the stock declined more than 10% intraday on the miss and guidance, making ABT one of the larger percentage decliners on the S&P 500 on that session (source: Benzinga/Barchart coverage of the earnings day).
- The FDA approved Abbott’s Volt PFA System for atrial fibrillation in December 2025; regulatory approvals such as this can support longer-term optimism for the Devices segment.
- The FDA issued a safety alert in late 2025 for FreeStyle Libre 3 sensors after Abbott linked devices to several serious injuries and deaths; safety alerts can create short-term reputational and legal risk, affecting the abbott stock price.
- The announcement of the $21 billion Exact Sciences acquisition (Nov 2025) is a major corporate event that influenced valuation expectations and investor focus on integration risk and financing.
News flow and analyst commentary frequently drive short-term volatility in the abbott stock price.
Analyst coverage and market sentiment
Sell-side analysts publish ratings, price targets, and model updates that influence market sentiment around the abbott stock price. Aggregators compile consensus ratings and mean/median price targets across brokerages.
Illustrative notes from recent coverage (reported January 2026): some analysts trimmed price targets after the Q4 results while maintaining constructive ratings in several cases; for example, one notable brokerage reduced its price target but kept an Outperform rating. These revisions and commentary are part of why the abbott stock price reacted following the earnings and guidance release.
Institutional ownership and large shareholder filings can also signal investor conviction and influence price action; public 13F filings disclose large institutional holdings periodically.
Risks and investment considerations
The following principal risks are commonly cited and can influence the abbott stock price:
- Regulatory risk: approvals, clearances, inspections, and safety communications from bodies like the FDA
- Competitive risk: technological and product competition in devices, diagnostics and diabetes care
- Product recalls or safety events: safety alerts or adverse event reports can materially affect demand
- Geographic and currency exposure: international operations subject to regional policy changes and FX
- Execution risk from large M&A transactions and product launches
- Macroeconomic and market risks: interest rates, inflation, and investor risk appetite affect valuation multiples
This guide is factual and not investment advice. All readers should consult primary sources and licensed advisors before making investment decisions.
How to track, trade and research ABT
Where to monitor the abbott stock price:
- Company sources: Abbott investor relations page and SEC filings for authoritative corporate disclosures.
- Market data providers: Yahoo Finance, Google Finance, Morningstar, MarketWatch and CNBC for quote displays and metrics.
- Brokerage platforms: retail and institutional brokers provide executable quotes and order routing.
Trading practicalities (basic order types):
- Market order: executes immediately at available prices; likely to match the live abbott stock price but may cross spreads.
- Limit order: set a maximum buy or minimum sell price to control execution price.
- Extended-hours orders: many brokers allow pre-market and after-hours orders; expect thinner liquidity and wider spreads.
Platform note: when choosing a trading venue for ABT, consider regulated brokers with transparent pricing and market access. For users of Bitget’s brokerage/trading services, Bitget provides equity trading access, order types and wallet integration; Bitget Wallet is the recommended non-custodial wallet when storing digital assets associated with trading accounts that support wallet connectivity. (This article does not provide investment advice.)
Data delay expectations: some portals show 15–20 minute delayed quotes for free users; verified real-time quotes are available via broker platforms or paid market-data subscriptions.
Historical corporate actions and notable price events
Timeline of selected, verifiable corporate events that materially affected the abbott stock price:
- 2013 — AbbVie spinoff: Abbott separated its research-based pharmaceutical business to create AbbVie (a notable historical corporate action affecting Abbott's long-term structure).
- December 2025 — FDA approval: Volt PFA System for atrial fibrillation received FDA approval; regulatory approvals often support positive sentiment for device revenue trajectories.
- November 2025 — Acquisition announcement: Abbott agreed to acquire Exact Sciences in a transaction valued at approximately $21 billion, a major strategic move affecting investor valuation assumptions.
- Q4 CY2025 earnings (reported Jan 2026) — Sales miss and conservative near-term guidance: reported Q4 sales of $11.46 billion and adjusted EPS of $1.50; top-line missed consensus and guidance for 2026 led to a sharp intraday decline in the abbott stock price in follow-up trading sessions (reported Jan 24, 2026 by market outlets).
- Late 2025 — Safety alert: regulatory safety communication related to FreeStyle Libre 3 sensors, which had reputational and potential legal implications; such safety alerts often pressure short-term price performance.
For a full corporate timeline and exact dates, consult Abbott’s investor relations archive and SEC filings.
See also
- Abbott Laboratories (company profile)
- ABT (ticker) profile pages on major data providers
- Peers in medical devices and diagnostics
- Healthcare and medtech sector indices and ETFs
References
Sources used to inform this article include company disclosures and major market data and news providers. For timely price checks and original documents consult:
- Abbott investor relations reports and press releases (company filings)
- Major financial data providers and news outlets (examples: Yahoo Finance, Google Finance, Morningstar, MarketWatch, CNBC, Robinhood)
- News coverage and market summaries reporting on Q4 CY2025 results (e.g., Benzinga, Barchart coverage dated January 24, 2026)
Note: this article quoted reported figures and contextual market reactions as presented in news reports dated in January 2026. Readers should verify the most recent abbott stock price and metrics through live market data feeds or Abbott’s official investor communications.
External links
(For convenience, search these sources by name in your browser or within your trading platform — direct URLs were intentionally omitted here):
- Abbott investor relations (stock prices and filings)
- Yahoo Finance — ABT quote
- Google Finance — ABT:NYSE
- MarketWatch — ABT quote
- Morningstar — ABT profile
- CNBC — ABT: Abbott Laboratories
Notes on data timeliness: market prices and valuation metrics change continuously; always confirm the current abbott stock price on a live market feed before making any trading decisions.
Notes on scope, updates and data verification
- This article summarizes public, verifiable information about the abbott stock price using company disclosures and mainstream market data sources. It does not provide financial advice or recommendations.
- Reported earnings, guidance, share counts, market capitalization and other quantitative metrics should be verified from the primary sources (company press releases, SEC filings) and updated in this article following new quarterly reports or material corporate actions.
- On-chain metrics do not apply to ABT; ABT is an equity issued by a public company and not a blockchain asset.
Practical checklist to follow the abbott stock price (quick how-to)
- For a live quote, open your brokerage platform (Bitget recommended for brokerage access) or a major market data provider.
- Verify the quote is labeled ABT on the NYSE and confirm whether the feed is real-time or delayed.
- Before earnings or major events, review the company press release archive and recent SEC filings for guidance and context.
- Use limit orders to control execution price during volatile sessions (e.g., earnings releases) and be cautious with market orders in extended hours when spreads can widen.
- For long-term return calculations, use total-return charts that incorporate dividends and consider the effect of buybacks or dilution from acquisitions.
Further exploration: for updates on ABT’s latest abbott stock price movement and to trade with an integrated wallet and order management, explore Bitget’s brokerage services and Bitget Wallet features.
(End of article.)
